Neuro-ophthalmic Mechanisms Of Disease
Neuro-ophthalmic Mechanisms Of Disease
批准号:
8556824
负责人:
Edmond J FitzGibbon
金额:
$21.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Acoustic NeuromaAffectAgeAnesthesia proceduresAnteriorBlindnessBrain DiseasesBrain PartCataractCharacteristicsClinicClinicalCollaborationsComplicationCorneaDegenerative DisorderDentalDiagnosisDiseaseDisease ProgressionDysplasiaEnrollmentEtiologyExhibitsEyeEye MovementsFacial paralysisFrequenciesGaucher DiseaseGenerationsGenotypeGliomaGoalsGuidelinesHamartomaHereditary DiseaseImageIncidenceInstitutesIrisLaboratoriesLeadLisch nodulesMeasuresMeta-AnalysisMotionNatural HistoryNeuraxisNeurodegenerative DisordersNeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2NeurologicOcular Motility DisordersOperative Surgical ProceduresOptic NerveOutcomePatient observationPatientsPhenotypePlexiform NeurofibromaProcessProtocols documentationPublicationsPublishingReportingRetinalRiskSaccadesSomatotrophin increasedSomatotropinSphenoid bone structureStagingStimulusSubacute Neuronopathic Gaucher DiseaseSystemTechniquesTestingTimeTissuesTwin Multiple BirthUnited States National Institutes of HealthVisionVisual MotionWingbonecell motilitycohortcraniofacialdisease natural historyeye drynessinsightmeetingsnerve decompressionoculomotoroptic nerve disorderresponseskull base
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this report I will concentrate on studies of various neuro-degenerative diseases which have characteristic oculomotor abnormalities, and also in diseases that affect the optic nerve or have neuro-ophthalmic consequences such as fibrous dysplasia and neurofibromatosis.
Oculomotor control is distributed throughout the brain, and diseases differentially affecting parts of the brain can affect eye movements in different, and often specific ways. We have recorded eye movements in patients with neurodegenerative and genetic diseases to characterize their ocular motility disorder, to help make a specific diagnosis, to correlate phenotype to genotype, to stage disease progression, and to give insight into the processes underlying eye movement generation.
We recently published the results of following a cohort of 15 patients with Gaucher type 3 disease. Significant findings include vertical saccade slowing with downward saccades more severely affected and evidence of slow progression of the disease with time as noted by saccadic recordings. Another publication examined twins with Gaucher disease exhibiting highly discordant Gaucher phenotypes demonstrating the poor predictability of phenotype given a specific genotypic diagnosis.
Fibrous dysplasia (FD) is a disease where normal bone is replaced with fibro-osseous tissue. In the polyostotic form, the anterior cranial base is frequently involved, including the sphenoid bones. The optic nerve passes through the sphenoid wing and is often found to be encased by FD on CT imaging. The management of fibrous dysplasia encased optic nerves is controversial, as optic neuropathy resulting in vision loss is the most frequently reported neurological complication. In collaboration with Dr. Michael Collins of the Dental Institute, a cohort of more than 80 patients with fibrous dysplasia continue to be followed longitudinally with neuro-ophthalmologic exams to track the natural history of this disease. In the past year a meta-analysis was published comparing watchful waiting versus optic nerve decompression surgery in craniofacial fibrous dysplasia. The study confirmed that watchful waiting is the recommended course. Another publication presented the outcome of a meeting held at NIH on fibrous dysplasia along with recommended clinical guidelines. Lastly, a preliminary report comparing two groups with controlled and uncontrolled high growth hormone levels suggested that controlling excess growth hormone from a young age reduces the risk of optic neuropathy.
Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder. Plexiform neurofibromas develop in about 25% of patients and these are among the most debilitating complication of NF1. There is also a higher incidence of central nervous system gliomas and other neuro-ophthalmic manifestations. In collaboration with Brigitte Wideman of NCI, NF1 patients are being enrolled in a natural disease study and continue to be examined in the eye clinic. Longitudinally,several parameters are followed including Lisch nodules, vision, and ocular motility. Complete neuro-ophthalmic exams and imaging are performed. Currently we are examining the irides of these patients for comparison of their Lisch nodules with other disease measures.
Another ongoing natural history protocol follows patients with neurofibromatosis type 2 (NF2). These patients have acoustic neuromas and compression from these (or from surgical correction of vestibular schwannomas) can lead to facial palsy with poor lid closure, corneal anesthesia, and dry eyes. These complications put their eyes at risk for vision loss. NF2 patients may also present with cataracts and retinal hamartomas.
In collaboration with Boris Sheliga and Christian Quaia of the NEI, we continue to probe the visual motion system using ocular following response techniques pioneered by Fred Miles of the NEI. In the past year two publications examined the interactions of size and sppatial frequency of moving vertical sine wave gratings and on their spatial arrangement. These approaches use the machine like eye movements made in response to differing stimuli to help understand the mechanisms underlying motion vision.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:6826927
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:7322372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:10706104
-
项目类别:
-
资助金额:$38.51万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:8339766
-
项目类别:
-
资助金额:$29.5万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:7594074
-
项目类别:
-
资助金额:$43.27万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:10930504
-
项目类别:
-
资助金额:$76.98万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:8149158
-
项目类别:
-
资助金额:$28.09万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:10266878
-
项目类别:
-
资助金额:$54.11万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:8938309
-
项目类别:
-
资助金额:$21.82万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:6968567
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:7968330
-
项目类别:
-
资助金额:$30.62万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:7141736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:6672794
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:10019988
-
项目类别:
-
资助金额:$27.26万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:9362374
-
项目类别:
-
资助金额:$25.98万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:8737626
-
项目类别:
-
资助金额:$21.28万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
Neuro-ophthalmic Mechanisms Of Disease
-
批准号:7734618
-
项目类别:
-
资助金额:$35.43万
-
财政年份:--
-
负责人:Edmond J FitzGibbon
-
依托单位:
海外基金